US equities
|
MU
$1,065.24
▼-2.09%
NVDA
$236.18
▼-0.54%
PLTR
$199.90
▲+2.98%
SNDK
$1,639.11
▼-3.15%
AMD
$634.58
▼-1.75%
INTC
$108.99
▼-3.65%
META
$723.21
▲+0.26%
SPCX
$164.40
▼-1.91%
MU
$1,065.24
▼-2.09%
NVDA
$236.18
▼-0.54%
PLTR
$199.90
▲+2.98%
SNDK
$1,639.11
▼-3.15%
AMD
$634.58
▼-1.75%
INTC
$108.99
▼-3.65%
META
$723.21
▲+0.26%
SPCX
$164.40
▼-1.91%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about NASDAQ:ATOS,NASDAQ:OCGN
Recent news which mentions NASDAQ:ATOS,NASDAQ:OCGN
Atossa Therapeutics May Look Tempting, but There’s No Reason to Get in Now
August 30, 2021
Tickers
ATOS
OCGN
Tags
Market News
Penny Stocks
OCGN
From
InvestorPlace